Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

The selection and schedule of treatment should depend on patient preference and toxicity potential, according to Azka Ali, MD.

Physiomics said its software was initially developed to help clinicians with chemotherapy dosing decisions, but the results of a Partner study in January 2023 indicated that the software could be ...

Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate ...

Young patients with low-risk, relapsed Hodgkin lymphoma may be able to avoid transplant, data from 3 studies suggest.

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate ...

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

High-grade neutropenia was a concerning toxicity of ... against the investigator's choice of chemotherapy. STRO anticipates being well-positioned to pursue an Accelerated Approval for luveltamab ...